OxSonics – A breakthrough drug delivery platform

Increased efficacy
Decreased toxicity
Therapeutics ENHANCED

Learn more
Drug-agnostic delivery platform
No drug reformulation
Active Partnering Programme

Learn more
Tackling the toughest cancers
Pipeline of ground-breaking therapies

Learn more

About OxSonics^®

OxSonics Therapeutics’ proprietary platform technology SonoTran^®, has been developed to enable a step-change in the therapeutic index of anti-cancer agents without the development costs or delays associated with drug reformulation.

Find out how SonoTran works

Latest News

OxSonics Launches New Website & Renames as OxSonics Therapeutics 7 January 2019
OxSonics’ Cofounder Professor Coussios Presents at the Royal Society 24 October 2018
OxSonics to Present at the International Oncolytic Virus Congress 2018 12 April 2018

Events

The 24th Symposium on Ultrasound Contrast Imaging
17 – 18 January 2019
Rotterdam, Netherlands
8th Partnerships in Drug Delivery Conference
7 – 8 October 2019
Boston, USA